NCT02925598

Brief Summary

The standard procedure used for airway control in general anesthesia for LC (laparoscopic cholecystectomy) is endotracheal intubation (EI). AuraGain and I-Gel are supraglottic airway devices (SADs) used for airway control for certain types of surgeries. The aim of this study was to evaluate and compare the performances of new types of SADs with EI regarding their insertion times, durations, perioperative complications and effects on hemodynamic parameters and peak airway pressures (Paw) in LC as well.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

September 5, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 6, 2016

Completed
Last Updated

May 9, 2017

Status Verified

May 1, 2017

Enrollment Period

3 months

First QC Date

September 5, 2016

Last Update Submit

May 6, 2017

Conditions

Keywords

Laringeal masksCholecystectomy, LaparascopicIntubation, intratracheal

Outcome Measures

Primary Outcomes (3)

  • Insertion time

    It was assessed that how many secs it takes to insert the device

    Perioperative

  • Attempts to insertion

    It was assessed that how many attempts needed to insert the device

    Perioperative

  • Airway related complications

    Airway related complications like bronchospasm,gastric regurgitation,smooth tissue damages were assessed

    Perioperative

Secondary Outcomes (4)

  • Heart Rate bpm

    Perioperative

  • Systolic blood pressure mmHg

    Perioperative

  • Diastolic blood pressure mmHg

    Perioperative

  • Peak airway pressure

    Perioperative

Study Arms (3)

I-gel LMA

EXPERIMENTAL

I-gel LMA insertion: I-gel insertion was done in supine position and with a standard gel pillow with the patient's head on following anesthesia induction. The insertion was verified with the manual ventilation of the patient and EtCO2 waveform.

Device: I-gel LMA insertion

AuraGain LMA

EXPERIMENTAL

AuraGain insertion:AuraGain LMA insertion was done in supine position and with a standard gel pillow with the patient's head on following anesthesia induction. The insertion was verified with the manual ventilation of the patient and EtCO2 waveform.

Device: AuraGain LMA insertion

Endotracheal tube (ETT)

EXPERIMENTAL

Endotracheal tube insertion: Endotracheal tube (ETT) insertion was done in supine position and with a standard gel pillow with the patient's head on following anesthesia induction. The insertion was verified with the manual ventilation of the patient and EtCO2 waveform.

Device: ETT insertion

Interventions

'I-gel LMA insertion' was done following anesthesia induction.

I-gel LMA

'AuraGain LMA insertion' was done following anesthesia induction.

AuraGain LMA

'ETT insertion' was done following anesthesia induction.

Endotracheal tube (ETT)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (ASA) 1-2 physical status scheduled for elective LC

You may not qualify if:

  • under the age of 18, history of hiatus hernia, gastroesophageal reflux, body mass index (BMI) \> 30 kg m-2, ASA physical status 3 or over and patients who met the difficult intubation criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Ulku Sabuncu, MD

    Adiyaman university Research and Educational Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Ulku Sabuncu, MD, Anesthesiology and Reanimation

Study Record Dates

First Submitted

September 5, 2016

First Posted

October 6, 2016

Study Start

January 1, 2015

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

May 9, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share